Antilymphocyte globulin versus OKT3 induction therapy in cadaveric kidney transplantation: a prospective randomized study (Q67601702)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1462990%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

title

Antilymphocyte globulin versus OKT3 induction therapy in cadaveric kidney transplantation: a prospective randomized study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1462990%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1462990

29 September 2022

author name string

J. M. Grino

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1462990

29 September 2022

A. M. Castelao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1462990

29 September 2022

D. Serón

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1462990

29 September 2022

C. Gonzalez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1462990

29 September 2022

J. M. Galceran

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1462990

29 September 2022

S. Gil-Vernet

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1462990

29 September 2022

E. Andrés

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1462990

29 September 2022

M. Mestre

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1462990

29 September 2022

J. Torras

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1462990

29 September 2022

J. Alsina

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1462990

29 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1462990

29 September 2022

publication date

1 December 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1462990%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

15 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1462990%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1462990%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1462990%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

page(s)

603-610

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1462990%20AND%20SRC:MED&resulttype=core&format=json

Sequential antilymphocyte globulin/cyclosporine immunosuppression in cadaveric renal transplantation. Effect of duration of ALG therapy

15 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970227-5

7 January 2021

Antilymphoblast globulin, cyclosporine, and steroids in cadaveric renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970227-5

7 January 2021

A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970227-5

7 January 2021

Muromonab CD3. A review of its pharmacology and therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970227-5

7 January 2021

OKT3 treatment of steroid-resistant renal allograft rejection.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970227-5

7 January 2021

Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970227-5

7 January 2021

Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970227-5

7 January 2021

Mechanisms maintaining transplantation tolerance in antithymocyte globulin-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970227-5

7 January 2021

Hard graft? Future challenges in transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970227-5

7 January 2021

Recognition of self within self: specific lymphocyte positioning and the extracellular matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970227-5

7 January 2021

Influence of low-dose cyclosporine on the outcome of treatment with OKT3 for acute renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970227-5

7 January 2021

Possible nephrotoxicity of the prophylactic use of OKT3 monoclonal antibody after cadaveric renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970227-5

7 January 2021

Improved results using OKT3 as induction immunosuppression in renal allograft recipients with delayed graft function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970227-5

7 January 2021

Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970227-5

7 January 2021

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970227-5

7 January 2021

Successful retreatment of allograft rejection with OKT3

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970227-5

7 January 2021

Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970227-5

7 January 2021

A flow cytometric method for the detection of the development of antibody to Orthoclone OKT3.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970227-5

7 January 2021

10.1016/S0272-6386(12)70227-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1462990%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

1 reference